[Bupranolol eye-drops (Ophtorenin) in long-term therapy of glaucoma (author's transl)].

A clinical study with Bupranolol (Ophtorenin), a beta adrenergic blocking agent, is presented. 85 eyes with kinds species of glaucoma were treated during 22 months. A satisfying hypotensive effect was attained in a high percentage. Suitable combinations with Clonidine and Acetazolamide were tested. Based on its atoxic properties and lack of adverse reactions Bupranolol represents a valuable enlargement of glaucoma therapy.